Investments
Intarcia Therapeutics, Inc.
Biopharmaceutical developer of therapies for life-threatening diseases utilizing the Company’s DUROS® delivery technology
Sector: Biopharmaceuticals, Healthcare
Company Status: Private
Investment Status: Current
Board Members:
Ed Mathers